Companies who implement strategies to increase adherence and persistence with their products can better face the numerous challenges in today’s market, and increase their share of profits. But how does a company even begin?
This report from Eularis looks at the formidable barriers pharma companies face in improving adherence, elements of successful adherence programs and methods for ensuring the best ROI.
To read the full report, please click here www.eyeforpharma.com/andreepc.pdf
Author: Dr. Andree K. Bates, managing director, Eularis
